Results 191 to 200 of about 46,962 (257)

Dasatinib inhibits PD-L1 expression via a proteasomal pathway in pancreatic ductal adenocarcinoma cells. [PDF]

J Cancer
Ko CC, Li HY, Yang PM.
europepmc   +1 more source

Phospho-Proteomic Analysis of Interleukin-13 Signaling in Airway Cells Reveals SRC Family Kinase Involvement in Interleukin-13-Induced Inflammatory Responses. [PDF]

Int Arch Allergy Immunol
Shankar A, McAlees JW, Wyder MA, Hargis JM, Ediga HH, Cannata A, Latayan J, Greis KD, Madala SK, Lewkowich IP.   +9 more
europepmc   +1 more source

Markov Chain Monte Carlo Bayesian Analysis for Population Pharmacokinetics of Dasatinib in Japanese Adult Subjects with Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

, 2012
Hiroyuki Yoshitsugu, Yasuhiko Imai, Taku Seriu, Masaki Hiraoka   +3 more
openalex   +2 more sources

Longitudinal analysis of usage and public awareness of tyrosine kinase inhibitors for CML. [PDF]

Front Oncol
Schroer AE, Javadi T, Mehta A, Torlak F, McFarland JR, Kumar G, da Silva AL, Benjamin J, Choudhary MM, Sadeghi A, le Coutre P, Blaha MJ, Berning P, Dzaye O.   +13 more
europepmc   +1 more source

Philadelphia chromosome-positive de novo myelodysplastic syndrome with the p230 BCR::ABL1 fusion gene: a case report. [PDF]

Int J Hematol
Kawai H, Fukushima H, Nannya Y, Onizuka M, Ogawa Y, Kawada H.   +5 more
europepmc   +1 more source

Auswirkungen einer Langzeitexposition mit den Tyrosinkinase-Inhibitoren Imatinib, Dasatinib und Bosutinib auf das Skelett und weitere Organsysteme im neu etablierten Tiermodell der juvenilen Ratte

, 2012
Josephine T. Tauer
openalex   +1 more source

Dasatinib-induced pulmonary arterial hypertension complicated with scleroderma: a case report [PDF]

, 2019
Takumi Toya, Yuji Nagatomo, Kazuki Kagami, Takeshi Adachi   +3 more
openalex   +1 more source

Cytotoxic and senescence-inducing effects of BLU554 in pancreatic ductal adenocarcinoma: an in vitro study. [PDF]

BMC Cancer
Fujiwara M, Shinji S, Shichi Y, Nonaka K, Hasegawa Y, Takahashi K, Rokutan H, Arai T, Ishiwata T.   +8 more
europepmc   +1 more source

Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without dasatinib for glioblastoma. [PDF]

Neuro Oncol
Breen WG, Dixon JG, Anderson SK, Sarkaria JN, Brown PD, Yan ES, Kizilbash S, Galanis E, Anderson D, Tran D, Mazurczak M, Johnson DR, Geoffroy FJ, Leinweber C, Laack NN.   +14 more
europepmc   +1 more source

RA-risk synovium exhibits DNA damage coupled with impaired DNA repair in fibroblasts. [PDF]

RMD Open
O'Byrne AM, de Jong TA, Semmelink JF, Krawczyk PM, Hoebe RA, van de Sande M, van Baarsen L.   +6 more
europepmc   +1 more source